aVaxziPen’s needle-free vaccine yields positive data across multiple diseases

18th May 2023

Originally published in LABIOTECH aVaxziPen, a biotech company developing a novel needle-free vaccine delivery platform, presented data at the World Vaccine Congress (WVC) in Washington, U.S., recently.  The company presented a poster entitled, “Needle-free, injectable solid dose vaccine delivery generates equivalent immune response with different antigens and animal models.” The company said immunogenicity data from… read more